Wednesday, December 13, 2006

Health Canada Endorsed Important Safety Information on Iressa (gefitinib)

From Health Canada:
Lack of Survival Benefit and Increased Incidence of Tumour Haemorrhage in Association with IRESSA® in Patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN ...more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)